NASDAQ:IRIX IRIDEX (IRIX) Stock Price, News & Analysis $0.64 +0.01 (+1.77%) Closing price 10/2/2026 03:49 PM EasternExtended Trading$0.63 -0.01 (-1.43%) As of 10/2/2026 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About IRIDEX Stock (NASDAQ:IRIX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IRIDEX alerts:Sign Up Key Stats Today's Range$0.62▼$0.6550-Day Range$0.61▼$0.9352-Week Range$0.61▼$1.65Volume24,332 shsAverage Volume50,734 shsMarket Capitalization$11.30 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingHold Company Overview IRIDEX Corporation develops and markets ophthalmic laser systems and related delivery devices used by eye-care professionals. Its technologies are designed primarily to treat glaucoma and retinal diseases, including conditions that can lead to vision loss. The company’s product portfolio includes laser systems, probes and treatment delivery devices that support procedures such as MicroPulse cyclophotocoagulation and retinal photocoagulation. Its Cyclo G6 platform is used in glaucoma treatments, while its retinal laser products are intended for procedures involving diseases of the retina. Founded in 1989 and headquartered in Mountain View, California, IRIDEX serves ophthalmologists, hospitals, ambulatory surgery centers and other eye-care providers. The company markets its products in the United States and internationally through direct sales and distribution relationships.AI Generated. May Contain Errors. Read More IRIDEX Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreIRIX MarketRank™: IRIDEX scored higher than 28% of companies evaluated by MarketBeat, and ranked 754th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingIRIDEX has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialIRIDEX has a consensus price target of $3.00, representing about 366.4% upside from its current price of $0.64.Amount of Analyst CoverageIRIDEX has only been the subject of 1 research reports in the past 90 days.Read more about IRIDEX's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of IRIDEX is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IRIDEX is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about IRIDEX's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.00% of the float of IRIDEX has been sold short.Short Interest Ratio / Days to CoverIRIDEX has a short interest ratio ("days to cover") of 2.56, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IRIDEX has recently increased by 8.10%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIRIDEX does not currently pay a dividend.Dividend GrowthIRIDEX does not have a long track record of dividend growth. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for IRIDEX this week, compared to 1 article on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IRIDEX insiders have not sold or bought any company stock.Percentage Held by Insiders8.60% of the stock of IRIDEX is held by insiders.Percentage Held by Institutions20.10% of the stock of IRIDEX is held by institutions.Read more about IRIDEX's insider trading history. Receive IRIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRIX Stock News HeadlinesAnalyzing PROCEPT BioRobotics (NASDAQ:PRCT) and IRIDEX (NASDAQ:IRIX)October 2 at 5:16 AM | americanbankingnews.comIRIDEX (NASDAQ:IRIX) Stock Breaks Below 200 Day Moving Average - Here's What HappenedSeptember 30, 2026 | americanbankingnews.comA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income. Some investors are targeting $5,000 a month with roughly one-tenth of the nest egg Wall Street says you need.October 4 at 1:00 AM | Investors Alley (Ad)Iridex: Q2 Earnings SnapshotAugust 18, 2026 | chron.comIridex reaffirms 2026 revenue guidance of $51m-$53m while highlighting working-capital build tied to headquarters relocationAugust 18, 2026 | seekingalpha.comIRIDEX Corporation (IRIX) Q2 2026 Earnings Call TranscriptAugust 18, 2026 | seekingalpha.comIridex Reports Second Quarter 2026 Financial ResultsAugust 18, 2026 | globenewswire.comIridex to Report Second Quarter 2026 Financial Results on August 18, 2026August 4, 2026 | globenewswire.comSee More Headlines IRIX Stock Analysis - Frequently Asked Questions How have IRIX shares performed this year? IRIDEX's stock was trading at $1.14 at the beginning of 2026. Since then, IRIX shares have decreased by 43.6% and is now trading at $0.6432. How were IRIDEX's earnings last quarter? IRIDEX Corporation (NASDAQ:IRIX) released its quarterly earnings data on Tuesday, August, 18th. The medical equipment provider reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.06. The medical equipment provider had revenue of $12.57 million for the quarter, compared to analysts' expectations of $13.59 million. Read the conference call transcript. How do I buy shares of IRIDEX? Shares of IRIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IRIDEX own? Based on aggregate information from My MarketBeat watchlists, some other companies that IRIDEX investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET) and CrowdStrike (CRWD). Company Calendar Last Earnings8/18/2026Today10/04/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 IRIX's financial health is in the Red zone, according to TradeSmith. IRIX has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:IRIX CIK1006045 Webwww.iridex.com Phone(650) 940-4700Fax650-940-4710Employees108Year Founded1989Price Target and Rating Average Price Target for IRIDEX$3.00 High Price Target$3.00 Low Price Target$3.00 Potential Upside/Downside+366.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$4.44 million Net Margins-6.88% Pretax Margin-6.58% Return on EquityN/A Return on Assets-12.55% Debt Debt-to-Equity RatioN/A Current Ratio1.82 Quick Ratio1.08 Sales & Book Value Annual Sales$51.57 million Price / Sales0.22 Cash FlowN/A Price / Cash FlowN/A Book Value($0.06) per share Price / Book-10.72Miscellaneous Outstanding Shares17,565,000Free Float16,054,000Market Cap$11.30 million OptionableOptionable Beta0.67 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:IRIX) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
